| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | ACT ELISA Kit; ACTB ELISA Kit; ACTG ELISA Kit; ACTG_HUMAN ELISA Kit; actg1 ELISA Kit; Actin ELISA Kit; Actin; cytoplasmic 2 ELISA Kit; Actin; gamma 1 ELISA Kit; Actin; gamma 1 propeptide ELISA Kit; Actin; gamma ELISA Kit; BRWS2 ELISA Kit; cytoplasmic 2 ELISA Kit; Cytoskeletal gamma actin ELISA Kit; Deafness; autosomal dominant 20 ELISA Kit; Deafness; autosomal dominant 26 ELISA Kit; DFNA20 ELISA Kit; DFNA26 ELISA Kit; epididymis luminal protein 176 ELISA Kit; Gamma-actin ELISA Kit; HEL-176 ELISA Kit; N-terminally processed ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Actin, cytoplasmic 2(ACTG1) is a biological molecule commonly studied in signal transduction research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P63261
Biological context
Researchers often monitor Actin, cytoplasmic 2(ACTG1) in serum, plasma, tissue homogenates, and cell lysates to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Actin, cytoplasmic 2(ACTG1) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Actin, cytoplasmic 2(ACTG1) may also appear under names such as ACT and ACTB. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Actin, cytoplasmic 2(ACTG1) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
PJ Woll,British journal of cancer,2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS)
PJ Woll,British journal of cancer,2023
Discovery, validation, and diagnostic ability of multiple protein-based biomarkers in saliva and gingival crevicular fluid to distinguish between health and periodontal diseases
MM Grant,Journal of clinical periodontology,2022